Panagora Asset Management Inc. Has $1.64 Million Stake in Molina Healthcare, Inc. (MOH)

Panagora Asset Management Inc. cut its holdings in shares of Molina Healthcare, Inc. (NYSE:MOH) by 52.0% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 11,001 shares of the company’s stock after selling 11,934 shares during the period. Panagora Asset Management Inc.’s holdings in Molina Healthcare were worth $1,636,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also modified their holdings of the company. Advisors Asset Management Inc. lifted its position in Molina Healthcare by 2,264.2% in the second quarter. Advisors Asset Management Inc. now owns 93,813 shares of the company’s stock worth $118,000 after purchasing an additional 89,845 shares during the period. Integrated Investment Consultants LLC acquired a new stake in Molina Healthcare in the second quarter worth approximately $165,000. DekaBank Deutsche Girozentrale lifted its position in Molina Healthcare by 185.1% in the third quarter. DekaBank Deutsche Girozentrale now owns 1,226 shares of the company’s stock worth $170,000 after purchasing an additional 796 shares during the period. Alpha Cubed Investments LLC acquired a new stake in Molina Healthcare in the third quarter worth approximately $200,000. Finally, CIBC Asset Management Inc acquired a new stake in Molina Healthcare in the second quarter worth approximately $211,000.

Shares of NYSE:MOH opened at $131.72 on Friday. Molina Healthcare, Inc. has a one year low of $71.07 and a one year high of $154.06. The firm has a market cap of $8.22 billion, a PE ratio of 18.76, a P/E/G ratio of 1.43 and a beta of 1.53. The company has a debt-to-equity ratio of 0.78, a current ratio of 1.40 and a quick ratio of 1.40.

Molina Healthcare (NYSE:MOH) last announced its quarterly earnings data on Wednesday, October 31st. The company reported $2.55 EPS for the quarter, beating analysts’ consensus estimates of $1.65 by $0.90. Molina Healthcare had a return on equity of 30.50% and a net margin of 1.27%. The company had revenue of $4.70 billion during the quarter, compared to the consensus estimate of $4.72 billion. During the same quarter in the prior year, the firm earned ($1.62) EPS. The company’s quarterly revenue was down 6.6% compared to the same quarter last year. On average, equities research analysts expect that Molina Healthcare, Inc. will post 8.12 EPS for the current year.

In other news, insider James Woys bought 25,000 shares of the business’s stock in a transaction on Wednesday, September 19th. The shares were bought at an average cost of $148.79 per share, with a total value of $3,719,750.00. Following the purchase, the insider now directly owns 17,203 shares in the company, valued at $2,559,634.37. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, Director Dale B. Wolf sold 4,000 shares of the business’s stock in a transaction on Friday, November 9th. The shares were sold at an average price of $135.57, for a total transaction of $542,280.00. Following the sale, the director now directly owns 10,214 shares in the company, valued at $1,384,711.98. The disclosure for this sale can be found here. Over the last three months, insiders have sold 9,045 shares of company stock worth $1,172,076. Company insiders own 0.65% of the company’s stock.

A number of research firms have weighed in on MOH. Zacks Investment Research upgraded Molina Healthcare from a “hold” rating to a “strong-buy” rating and set a $155.00 target price for the company in a research report on Tuesday, October 23rd. Jefferies Financial Group upgraded Molina Healthcare from a “hold” rating to a “buy” rating and increased their price objective for the company from $152.00 to $169.00 in a research report on Tuesday, November 13th. Piper Jaffray Companies increased their price objective on Molina Healthcare to $165.00 and gave the company an “overweight” rating in a research report on Wednesday, September 26th. ValuEngine downgraded Molina Healthcare from a “buy” rating to a “hold” rating in a research report on Thursday, November 1st. Finally, Morgan Stanley increased their price objective on Molina Healthcare from $132.00 to $178.00 and gave the company an “overweight” rating in a research report on Wednesday, September 5th. One research analyst has rated the stock with a sell rating, seven have assigned a hold rating, five have given a buy rating and one has issued a strong buy rating to the company’s stock. Molina Healthcare presently has a consensus rating of “Hold” and a consensus price target of $131.92.

TRADEMARK VIOLATION NOTICE: This story was posted by WKRB News and is the sole property of of WKRB News. If you are accessing this story on another publication, it was copied illegally and republished in violation of U.S. & international trademark & copyright legislation. The legal version of this story can be accessed at https://www.wkrb13.com/2018/12/16/panagora-asset-management-inc-has-1-64-million-stake-in-molina-healthcare-inc-moh.html.

Molina Healthcare Company Profile

Molina Healthcare, Inc provides Medicaid-related solutions to meet the health care needs of low-income families and individuals; and to assist state agencies in their administration of the Medicaid program in the United States. It operates through three segments: Health Plans, Molina Medicaid Solutions, and Other.

Read More: Moving Average – How it Helps Investors in Stock Selection

Institutional Ownership by Quarter for Molina Healthcare (NYSE:MOH)

Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply